Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Research output: Contribution to journalEditorial

Fingerprint Dive into the research topics of 'Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?'. Together they form a unique fingerprint.